Vedere Bio ll

About:

Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.

Website: https://www.vederebio.com

Top Investors: Mission BioCapital, Samsara BioCapital, Foundation Fighting Blindness, Casdin Capital, Atlas Venture

Description:

Vedere is developing cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss from Inherited Retinal Degenerations (IRDs), as well as other causes of both genetic and non-genetic vision loss. While the vast majority of ocular gene therapies only limit the rate of inevitable vision loss, we aim to restore lost vision regardless of a patient’s underlying genetics or their stage of disease.